In oral squamous cell carcinomas, immunoreactivity for COX-2 was diffusely and uniformly present in the cytoplasm of tumor cells, with some variability observed across the histological samples, being more intense in invasive areas. Here, PTGS2 is linked to oral cavity squamous cell carcinoma.